Wells Fargo & Company »

Effector Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Effector Therapeutics shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Effector Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Effector Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Effector Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $147 314 0.47
2023-09-30 $177 297 0.60
2023-06-30 $65 79 0.84
2022-12-31 $31 74 0.43
2022-09-30 $0 72 0.00
2022-06-30 $0 66 0.00
2022-03-31 $0 60 0.00
2021-12-31 $0 59 0.00

More positions owned by Wells Fargo & Company

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Ishares Tr Core S&p500 Etf Put Option (IVV)
Vanguard Index Fds Mid Cap Etf Put Option (VO)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p Ttl Stk (ITOT)
JPMorgan Chase & Co. Put Option (JPM)
Amazon Call Option (AMZN)
NVIDIA Corporation Put Option (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
UnitedHealth (UNH)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Wells Fargo & Company

Top funds holding Effector Therapeutics

Parallel Advisors
Blackstone Group

View all funds holding Effector Therapeutics